Building out knowledge for a potential AML immunotherapy

  The paper “Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia” published in The Proceedings of the National Academy of...

A CDC-trained disease detective conducts a Zika case investigation

Oily molecules key to Zika virus replication, infection

Zika virus emerged as a threat to global health in 2016 when it was linked to a spike in cases of microcephaly in newborns. In a modest rehearsal of what we’ve seen with SARS-CoV-2 research, there...

Tom Scanlan, Ph.D., and Meredith D. Hartley, Ph.D.

Thyroid drug corrects metabolic defect in a rare genetic disorder

In 2017, research led by Tom Scanlan, Ph.D., professor of chemical physiology and biochemistry, OHSU School of Medicine, found that sobetirome, a synthetic thyroid drug developed in his lab years ago...

Scientists suggest new solution to the rare-disease problem

Better definition could lead to better diagnosis and treatment for rare diseases that cumulatively affect millions  Thousands of rare diseases cumulatively affect millions of people across the...

Luiz Bertassoni

Technology Transfer Innovation Spotlight: Luiz Bertassoni

Every year, approximately 4,000 new cases of bone or joint-related cancer are diagnosed in the United States. Treatment and recovery can be painful — often requiring surgical removal of the...

Couple at the flower market

Understanding multimorbidity to close the health disparity gap

Multimorbidity — having two or more coexisting chronic conditions — is highly prevalent, costly and disabling to older adults. Across racial and ethnic groups, multimorbidity affects older adults...